Versatile 2-Oxoglutarate-Dependent Dioxygenases Catalyze Radical-Mediated Multifunctional Skeleton Reconstructions and Oxidation Modifications of Taxoids
Taxane diterpenoids exhibit high scaffold diversity, with 6/8/6 and 5/7/6 frameworks being the most common. 5/7/6 taxoids, exemplified by taxuspine J, display promising pharmacological activities, but their chemical diversity and biosynthesis remain largely unexplored. Here, we characterized two novel 2-oxoglutarate-dependent dioxygenases, TcOGD1 and TcOGD2, which exhibit remarkable catalytic versatility, including skeleton reconstructions from 6/8/6 taxanes to 5/7/6, <i>trinor</i>-5/7/6, and 6/12 frameworks, and oxidation modifications at C-5, C-6, C-16, or C-20 of various taxoids. Specifically, they catalyze the skeletal rearrangement of 2-deacetoxytaxinine J (a 6/8/6 taxoid) and subsequent oxidation modifications to produce taxuspine J and a panel of 15,16,17-<i>trinor</i>-5/7/6 taxoids, which were identified through scale-up enzymatic reactions and NMR spectroscopy. Mechanistic investigation reveals a substrate-specific oxidative degradation for constructing the <i>trinor</i>-5/7/6 scaffold via radical-mediated C-C bond cleavage, accompanied by acetone release. In addition, TcOGD1 catalyzes two distinct transformations of a new Δ<sup>5,6</sup> containing 6/8/6 taxoid isolated from <i>Taxus chinensis</i> var. <i>mairei</i>, including C-C bond cleavage coupled with aldehyde formation to form a unique highly unsaturated 6/12 taxoid, and C-16 aldehyde formation to yield a 6/8/6 taxoid. TcOGD1 also mediates the 5-OH oxidation of a 6/10/6 taxoid. Furthermore, five novel <i>trinor</i>-5/7/6 taxoids were isolated from the <i>Taxus</i> plant, and taxuspine J and <i>trinor</i>-5/7/6 taxoids showed effective tumor resistance reversal activity. Our findings offered new insights into the formation of taxane structural diversity, expanded the chemical space of taxane diterpenoids, and provided valuable biocatalytic tools for constructing unusual taxane architectures through enzyme engineering or synthetic biology.
Authors
- Yujie Zheng (ORCID: https://orcid.org/0000-0003-2484-8279)
- Xian-Jing Zhang
- Ruibo Wu (ORCID: https://orcid.org/0000-0002-1984-046X)
- Jie Chen (ORCID: https://orcid.org/0000-0003-3435-0351)
- Yun Wang (ORCID: https://orcid.org/0000-0001-9321-8946)
- Xi Zhang (ORCID: https://orcid.org/0000-0002-4638-3997)
- Yuyu Liu (ORCID: https://orcid.org/0000-0002-4814-8616)
- Li-Ping Long
- Chun-Lin Tan
- Xin-yu Fan
- Jia Liu
- Peng Zhang
- Fei-Yan Gou
- Jonathan Gershenzon
- Xue Tang
- Si Wu
- Sheng-Hong Li
- Chen Lin
- Yuan-Hui Yu
- Kai Guo
Institutions
- Fujian Normal University (CN)
- Kunming Institute of Botany (CN)
- Sun Yat-sen University (CN)
- Hainan University (CN)
- Key Laboratory of Guangdong Province (CN)
- Max Planck Institute for Chemical Ecology (DE)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1021/jacs.6c01169
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00